Total Payments
$2,443
2024 Payments
$123.30
Companies
30
Transactions
144
Medicare Patients
2,218
Medicare Billing
$173,619
Payment Breakdown by Category
Food & Beverage$2,443 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,443 | 144 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $552.93 | 30 | $0 (2021) |
| ABBVIE INC. | $311.39 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $150.90 | 11 | $0 (2022) |
| Novo Nordisk Inc | $144.73 | 9 | $0 (2023) |
| Astellas Pharma US Inc | $140.44 | 8 | $0 (2018) |
| Lilly USA, LLC | $128.89 | 10 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.45 | 8 | $0 (2021) |
| Allergan Inc. | $117.27 | 6 | $0 (2019) |
| PFIZER INC. | $68.53 | 5 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $67.71 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.30 | 6 | ABBVIE INC. ($63.23) |
| 2023 | $295.47 | 14 | AbbVie Inc. ($182.85) |
| 2022 | $103.49 | 7 | Lilly USA, LLC ($51.05) |
| 2021 | $225.16 | 15 | Lilly USA, LLC ($47.89) |
| 2020 | $40.19 | 3 | Nevro Corp. ($15.01) |
| 2019 | $217.98 | 13 | Amgen Inc. ($129.32) |
| 2018 | $636.96 | 36 | Amgen Inc. ($150.93) |
| 2017 | $800.33 | 50 | Amgen Inc. ($240.00) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/08/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $30.55 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: PAIN | ||||||
| 01/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: PAIN | ||||||
| 11/08/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: PAIN | ||||||
| 07/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Diabetes | ||||||
| 06/28/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/25/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Neuroscience | ||||||
| 04/12/2023 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Pain Management | ||||||
| 02/15/2023 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Pain Management | ||||||
| 01/18/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Neuroscience | ||||||
| 08/23/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Diabetes | ||||||
| 08/08/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Diabetes | ||||||
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 480 | 594 | $74,283 | $35,550 |
| 2022 | 13 | 570 | 1,656 | $120,705 | $59,257 |
| 2021 | 13 | 616 | 926 | $105,306 | $49,552 |
| 2020 | 13 | 552 | 691 | $70,442 | $29,260 |
Total Patients
2,218
Total Services
3,867
Medicare Billing
$173,619
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $29,737 | $15,940 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 92 | $18,124 | $7,375 | 40.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 39 | $10,374 | $4,713 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 81 | $11,745 | $4,354 | 37.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 127 | 166 | $1,826 | $1,386 | 75.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $849.75 | $791.23 | 93.1% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 24 | 38 | $456.00 | $361.76 | 79.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $858.00 | $314.82 | 36.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $168.00 | $168.16 | 100.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $145.60 | $145.74 | 100.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 124 | 124 | $28,148 | $15,275 | 54.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 901 | $29,733 | $15,033 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 135 | $26,595 | $11,548 | 43.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 49 | $13,034 | $6,099 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 75 | $10,199 | $3,969 | 38.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 14 | 14 | $4,794 | $3,524 | 73.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 14 | $2,548 | $1,847 | 72.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 140 | 191 | $2,101 | $565.53 | 26.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 46 | $2,365 | $462.36 | 19.5% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 24 | 38 | $456.00 | $349.25 | 76.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 27 | 28 | $313.60 | $314.67 | 100.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $210.00 | $210.17 | 100.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 26 | $208.00 | $57.70 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 118 | 118 | $26,786 | $14,776 | 55.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 148 | $29,156 | $12,199 | 41.8% |
About Dr. Kris Walker, MD
Dr. Kris Walker, MD is a Family Medicine healthcare provider based in Pocatello, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861500613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kris Walker, MD has received a total of $2,443 in payments from pharmaceutical and medical device companies, with $123.30 received in 2024. These payments were reported across 144 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,443).
As a Medicare-enrolled provider, Walker has provided services to 2,218 Medicare beneficiaries, totaling 3,867 services with total Medicare billing of $173,619. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Pocatello, ID
- Active Since 08/29/2006
- Last Updated 05/28/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1861500613
Products in Payments
- Prolia (Biological) $344.27
- QULIPTA (Drug) $149.99
- UBRELVY (Drug) $128.48
- EVENITY (Biological) $120.11
- FARXIGA (Drug) $116.26
- JARDIANCE (Drug) $89.37
- MYRBETRIQ (Drug) $84.11
- Proclaim Family of SCS IPGs (Device) $59.65
- Myrbetriq (Drug) $56.33
- EMGALITY (Drug) $56.19
- VRAYLAR (Drug) $56.02
- JANUVIA (Drug) $51.15
- TRULICITY (Drug) $48.32
- Repatha (Biological) $46.66
- ENTRESTO (Drug) $45.52
- NURTEC ODT (Drug) $44.09
- Aimovig (Biological) $41.89
- Prolastin-C (Biological) $40.18
- LINZESS (Drug) $38.02
- Kyleena (Drug) $37.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Pocatello
Ronald Solbrig, Md, MD
Family Medicine — Payments: $10,620
Family Medicine $10,620
Amber Frost, Fnp-C, FNP-C
Family Medicine — Payments: $9,356
Family Medicine $9,356
Dr. Brandon West, D.o, D.O
Family Medicine — Payments: $6,932
Family Medicine $6,932
Andrew Thayne, M.d, M.D
Family Medicine — Payments: $6,235
Family Medicine $6,235
Travis Nielsen, D.o, D.O
Family Medicine — Payments: $5,517
Family Medicine $5,517
Dr. Chance Christensen, Md, MD
Family Medicine — Payments: $3,957
Family Medicine $3,957